Point of Care Glucose Testing Market Is Predicted To Grow Due To Technological Advancements And Healthcare Convenience

27-Jun-2025 | Zion Market Research

The global point of care glucose testing market size was evaluated at $4.2 billion in 2023 and is slated to hit $6.4 billion by the end of 2032, with a CAGR of nearly 5.1% between 2024 and 2032.

Global Point of Care Glucose Testing Market Size

Point-of-care glucose testing devices are portable tools that provide immediate blood sugar readings outside the laboratory using fingerstick samples and electronic meters. New features include continuous glucose monitoring systems, smartphone connectivity, and cloud-based data management platforms. Better algorithms and smaller sample sizes have made testing easier and more reliable. Glucose monitoring is now more convenient, accurate, accessible, and well-integrated with digital health systems.

Browse the full “Point of Care Glucose Testing Market By Product (Blood Glucose Meters, Continuous Glucose Monitors, and Lancing Devices & Strips), By End-User (Home Use, Ambulatory Care Settings, Hospitals & Settings, Long-Term Care Facilities, Pharmacies, and Hospitals & Clinics), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032”- Report at https://www.zionmarketresearch.com/report/point-of-care-glucose-testing-market-size

The growth of the global point of care glucose testing industry is primarily driven by the increasing prevalence of diabetes worldwide, the growing demand for home healthcare solutions, and the advancement of sensor technologies for real-time health monitoring.

Market Growth Factors

Several factors are propelling the expansion of the point of care glucose testing market.

  • Disease prevalence: The growing number of people with diabetes worldwide increases the need for regular blood sugar checks, often multiple times a day.
  • Healthcare convenience: Point-of-care testing saves time by avoiding laboratory visits, gives quick results, and helps doctors make faster treatment decisions, which improves patient care.
  • Technology advancement: New glucose meters are more accurate, store data, and connect with mobile applications to help manage diabetes and share information with doctors.

Restraints

  • Cost considerations: Advanced glucose monitors and test supplies can be expensive, making them unaffordable for patients with low incomes or limited insurance.
  • Accuracy concerns: Differences in results between home testing devices and laboratory tests can lead to confusion for doctors and patients when making treatment decisions.

Point of Care Glucose Testing Market

Point of Care Glucose Testing Market: Report Scope

Report Attributes Report Details
Report Name Point of Care Glucose Testing Market
Market Size in 2023 USD 4.2 Billion
Market Forecast in 2032 USD 6.4 Billion
Growth Rate CAGR of 5.1%
Number of Pages 223
Key Companies Covered PTS Diagnostics, Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Acon Laboratories Inc., F. Hoffmann-La Roche Ltd., Dexcom Inc., Medtronic plc, LifeScan Inc., Becton, Dickinson and Company, Nova Biomedical Corporation, ARKRAY Inc., Trividia Health Inc., Ypsomed Holding AG, Nipro Diagnostics Inc., Sanofi S.A., and others.
Segments Covered By Product, By End-User, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Market Segmentation

The point of care glucose testing market can be segmented by product type, technology platform, end user category, distribution method, and region.

Based on product type, the market is divided into glucose meters, test strips, lancets and lancing devices, continuous glucose monitors, and calibration solutions. Test strips are expected to lead the market during the forecast period due to their consumable nature, which requires regular replacement and represents the highest volume component in glucose testing.

Based on technology platforms, the point of care glucose testing industry is categorized into electrochemical detection, optical measurement systems, biosensor technology, wireless connectivity features, and integrated data management platforms. Electrochemical detection leads the market due to its proven reliability, cost-effectiveness, and widespread adoption in commercial glucose monitoring devices.

Based on the end-user category, the market is segmented into home healthcare users, hospital departments, physician offices, diagnostic laboratories, and retail pharmacy clinics. Home healthcare users lead the market as most glucose testing occurs in residential settings where patients perform daily self-monitoring routines.

Based on the distribution method, the point of care glucose testing market is classified into retail pharmacy chains, online medical supply platforms, hospital procurement systems, and direct manufacturer sales programs. Retail pharmacy chains hold the largest market share due to their convenient locations, insurance processing capabilities, and established patient relationships for ongoing supply needs.

Asia-Pacific leads the global point of care glucose testing market due to its large diabetic population, rising health awareness, and better access to medical devices in developing countries. Rapid economic growth is increasing healthcare spending among the expanding middle class. Government programs and insurance plans are helping make these devices more widely available. Local manufacturing and competitive pricing are making glucose testing products more affordable. These factors are driving mass-market adoption across different income groups in the region.

Key Market Players

Leading companies operating in the global point of care glucose testing market include:

  • PTS Diagnostics
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Acon Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Dexcom Inc.
  • Medtronic plc
  • LifeScan Inc.
  • Becton
  • Dickinson and Company
  • Nova Biomedical Corporation
  • ARKRAY Inc.
  • Trividia Health Inc.
  • Ypsomed Holding AG
  • Nipro Diagnostics Inc.
  • Sanofi S.A.

 Recent Developments

  • In February 2025, Abbott Laboratories launched its FreeStyle Libre 3 Plus system, which features enhanced accuracy specifications, extended sensor duration, and improved smartphone integration, providing comprehensive diabetes management and connectivity for healthcare providers.

The global point of care glucose testing market is segmented as follows:

By Product

  • Blood Glucose Meters
  • Continuous Glucose Monitors
  • Lancing Devices & Strips

By End-User

  • Home Use
  • Ambulatory Care Settings
  • Hospitals & Settings
  • Long-Term Care Facilities
  • Pharmacies
  • Hospitals & Clinics

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed